[Correlation between C219 and drug resistance in lung neoplasms].
The authors take into consideration 19 cases of lung neoplasm to see the relationship of clinical behaviour and C219. They found a cutoff (25%) to separate drug resistant by drug sensibility. Marker sensitivity was 84.2% and relation with PCNA was negative (-0.384).
Oddi
G
G
Servizio di Anatomia ed Istologia Patologica, USL RM/10, Ospedale C. Forlanini, Roma.
De Angelis
G
G
Alma
M G
MG
De Marinis
F
F
Bigioni
D
D
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000032:analysis; D002352:Carrier Proteins / Q000032:analysis* / Q000276:immunology; D004311:Double-Blind Method; D004351:Drug Resistance; D006801:Humans; D008175:Lung Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000032:analysis* / Q000276:immunology; D009363:Neoplasm Proteins / Q000032:analysis* / Q000276:immunology; D009687:Nuclear Proteins / Q000032:analysis; D018809:Proliferating Cell Nuclear Antigen; D012189:Retrospective Studies
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen
Correlazione tra C219 e chemioresistenza nelle neoplasie del polmone.